Substantia Nigra Hyperechogenicity as a Marker for Parkinson's Disease: A Population-Based Study
Philipp Mahlknecht(University College London), Werner Poewe(Innsbruck Medical University), Johann Willeit(Innsbruck Medical University), Stefan Kiechl(Innsbruck Medical University), Gregorio Rungger(Krankenhaus Bruneck), Heike Stockner(Innsbruck Medical University), Michael Nocker(Innsbruck Medical University), Christoph Schmidauer(Innsbruck Medical University), Klaus Seppi(Innsbruck Medical University), Arno Gasperi(Krankenhaus Bruneck), Christoph Scherfler(Centre Hospitalier Universitaire de Lille)
Cited by 33
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k